Adrenal Washout Calculator for Radiology

Understanding Adrenal Washout in Radiology

Adrenal incidentalomas, often discovered serendipitously on cross-sectional imaging, are a common clinical challenge. The vast majority are benign adrenal adenomas, but a small percentage can represent malignant lesions (e.g., metastases, adrenocortical carcinoma) or hormonally active tumors (e.g., pheochromocytoma, Cushing's syndrome, aldosteronoma). Differentiating these lesions is crucial for appropriate patient management.

Computed Tomography (CT) with adrenal washout protocols plays a vital role in characterizing these lesions, particularly when the unenhanced Hounsfield Unit (HU) value is indeterminate (typically >10 HU).

What is Adrenal Washout?

Adrenal washout refers to the characteristic way benign adrenal adenomas lose contrast material rapidly compared to other adrenal lesions. This rapid washout is due to the presence of intracellular lipid within adenoma cells, which allows for quicker diffusion of contrast material out of the lesion.

Non-adenomatous lesions, such as metastases or pheochromocytomas, typically retain contrast for a longer duration, exhibiting slower washout. By quantifying this washout, radiologists can distinguish between benign and potentially malignant or functionally active lesions with high accuracy.

The Adrenal CT Scan Protocol for Washout

An adrenal washout study typically involves a multi-phase CT scan:

• Unenhanced CT: A baseline scan of the adrenal glands without intravenous contrast. This provides the initial HU value (HU_unenhanced) and helps identify lipid-rich adenomas (typically ≤10 HU).
• Immediate Post-contrast CT: Following intravenous contrast administration, an immediate scan (usually at 60-90 seconds, often corresponding to the portal venous phase) is performed. This provides the initial post-contrast HU value (HU_{initial post-contrast}).
• Delayed Post-contrast CT: A delayed scan, typically performed 15 minutes after contrast administration, captures the HU value (HU_{delayed post-contrast}) after the contrast has had time to wash out of the lesion.

Adrenal Washout Formulas

Two primary formulas are used to calculate adrenal washout percentages:

Absolute Washout Calculation

The Absolute Washout (AW) percentage compares the washout from the immediate post-contrast phase to the delayed phase, relative to the initial enhancement above baseline. It is calculated as:

Absolute Washout (%) = ((HUinitial post-contrast - HUdelayed post-contrast) / (HUinitial post-contrast - HUunenhanced)) * 100

• Interpretation: An Absolute Washout of > 60% is highly suggestive of a benign adrenal adenoma. Values ≤ 60% are indeterminate or suggest a non-adenoma.

Relative Washout Calculation

The Relative Washout (RW) percentage simplifies the calculation by comparing the washout from the immediate post-contrast phase to the delayed phase, relative only to the initial post-contrast enhancement. It is calculated as:

Relative Washout (%) = ((HUinitial post-contrast - HUdelayed post-contrast) / HUinitial post-contrast) * 100

• Interpretation: A Relative Washout of > 40% is highly suggestive of a benign adrenal adenoma. Values ≤ 40% are indeterminate or suggest a non-adenoma.

How to Use the Adrenal Washout Calculator

This calculator simplifies the process of determining adrenal washout percentages:

1. Enter Unenhanced CT HU: Input the Hounsfield Unit value measured from the adrenal lesion on the unenhanced CT scan.
2. Enter Immediate Post-contrast CT HU: Input the HU value measured from the same lesion on the immediate post-contrast scan (e.g., 60-90 seconds).
3. Enter Delayed Post-contrast CT HU: Input the HU value measured from the same lesion on the 15-minute delayed post-contrast scan.
4. Click "Calculate Washout": The calculator will instantly display both the Absolute and Relative Washout percentages, along with an interpretation based on established radiological criteria.

Ensure that the HU measurements are taken from the same region of interest (ROI) within the adrenal lesion across all three phases for accuracy.

Interpreting Your Results

The interpretation provided by the calculator is based on widely accepted thresholds:

• If the Unenhanced HU is ≤ 10, the lesion is highly likely to be a lipid-rich adenoma, and washout calculation may not be necessary.
• If Absolute Washout > 60% AND Relative Washout > 40%, the lesion is strongly indicative of a benign adrenal adenoma.
• If either or both percentages fall below these thresholds, the lesion is considered indeterminate or suggestive of a non-adenoma. This warrants further investigation, clinical correlation, and potentially biopsy or functional imaging.

It's important to remember that these are statistical probabilities, and clinical context always plays a critical role in final diagnosis and management.

Limitations and Clinical Considerations

While adrenal washout is a powerful tool, it has limitations:

• Lipid-poor adenomas: Some benign adenomas may be lipid-poor and thus have higher unenhanced HU values (>10) and potentially atypical washout kinetics.
• Small lesions: Accurate HU measurements can be challenging in very small lesions due to partial volume averaging.
• Hemorrhage/Necrosis: Lesions with significant hemorrhage or necrosis can show atypical enhancement patterns.
• Other lesions: Certain pheochromocytomas, myelolipomas without macroscopic fat, or cystic lesions can sometimes mimic adenomas or have confusing washout characteristics. Renal cell carcinoma metastases can also sometimes demonstrate rapid washout.
• Technical factors: Variations in contrast injection, timing of scans, and ROI placement can affect results.

Always integrate washout findings with the patient's clinical history, hormonal status, and other imaging features for a comprehensive assessment.

Conclusion

The adrenal washout calculator is a valuable aid for radiologists and clinicians in the workup of adrenal incidentalomas. By providing quick and accurate calculations of Absolute and Relative Washout percentages, it assists in distinguishing benign adenomas from other more concerning adrenal pathologies, guiding appropriate patient management and reducing unnecessary invasive procedures.